CNBC January 14, 2025
Annika Kim Constantino,Ashley Capoot,Bertha Coombs

Good afternoon from San Francisco! This week, Ashley and I are attending the annual JPMorgan Health Care Conference – the largest gathering of biotech and pharma execs, investors and analysts in the U.S.

The conference is a pulse for what to expect from the health-care industry in 2025. Executives from companies large and small highlighted their key business and drug pipeline updates, but also weighed in on the Trump administration’s potential impact on the sector and the outlook for the M&A and IPO markets.

Notably, the conference appears to have beefed up security around the main venue – the Westin St. Francis Hotel – this year in light of the killing of Brian Thompson, the CEO of UnitedHealth Group’s insurance...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Mergers & Acquisitions / JV, Trends
Where hospitals, health systems fall short in ASC joint ventures
Lantheus to acquire Life Molecular Imaging for up to $750 million, expanding Alzheimer's PET portfolio
Lantheus (LNTH) Acquires Life Molecular Imaging for $750M
Yale New Haven to extend transport services in acquisition
SuperDial Acquires MajorBoost, Enhancing AI-Powered Phone Automation

Share This Article